NEW YORK, Aug. 16 – Bayer’s recent announcement that it would consider merging its drug division even if it meant losing control of the business came as a surprise to many analysts who thought that Bayer, beset by plunging profits and a major drug recall, would seek a merger on the condition that it maintained management control.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.